
|Articles|October 17, 2012
Beware the changing playing field for physician-branded skincare product lines
Before pursuing the creation of a physician-branded skincare line, dermatologists should undertake a comprehensive analysis of the market and the development costs, said Frederic S. Brandt, M.D., at the 2012 annual meeting of the American Society for Dermatologic Surgery.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
JAK Inhibitors Show Comparable Safety to TNF Antagonists
2
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
3
Considering Biologics and Shared Decision-Making in Moderate to Severe Plaque Psoriasis: Part 2
4
"PDE4 Inhibitor-Responsive Dermatoses": A Modern Framework for Managing Inflammatory Skin Conditions
5


















